6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene

C192H114N26O4S4 — CID 158201031

IUPAC6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene
SMILESc1ccc(-c2cc(-c3nc4cc5c(cc4s3)oc3cc4sc(-c6cc(-c7ccccn7)nc(-c7ccccn7)c6)nc4cc35)cc(-c3ccccn3)n2)nc1.c1ccc(-c2cccc(-c3nc4cc5c(cc4n3-c3ccccc3)oc3cc4c(cc35)nc(-c3cccc(-c5ccccc5)c3)n4-c3ccccc3)c2)cc1.c1ccc(-c2cccc(-c3nc4cc5c(cc4s3)oc3cc4sc(-c6cccc(-c7ccccn7)n6)nc4cc35)n2)nc1.c1ccc(-n2c(-c3cccc(-c4nc5cc6c(cc5n4-c4ccccc4)oc4cc5c(cc46)nc(-c4cccc(-c6nc7ccccc7n6-c6ccccc6)c4)n5-c4ccccc4)c3)nc3ccccc32)cc1
InChIInChI=1S/C64H40N8O.C50H32N4O.C44H24N8OS2.C34H18N6OS2/c1-5-23-45(24-6-1)69-55-33-15-13-31-51(55)65-61(69)41-19-17-21-43(35-41)63-67-53-37-49-50-38-54-58(40-60(50)73-59(49)39-57(53)71(63)47-27-9-3-10-28-47)72(48-29-11-4-12-30-48)64(68-54)44-22-18-20-42(36-44)62-66-52-32-14-16-34-56(52)70(62)46-25-7-2-8-26-46;1-5-15-33(16-6-1)35-19-13-21-37(27-35)49-51-43-29-41-42-30-44-46(32-48(42)55-47(41)31-45(43)53(49)39-23-9-3-10-24-39)54(40-25-11-4-12-26-40)50(52-44)38-22-14-20-36(28-38)34-17-7-2-8-18-34;1-5-13-45-29(9-1)33-17-25(18-34(49-33)30-10-2-6-14-46-30)43-51-37-21-27-28-22-38-42(24-40(28)53-39(27)23-41(37)54-43)55-44(52-38)26-19-35(31-11-3-7-15-47-31)50-36(20-26)32-12-4-8-16-48-32;1-3-13-35-21(7-1)23-9-5-11-25(37-23)33-39-27-15-19-20-16-28-32(18-30(20)41-29(19)17-31(27)42-33)43-34(40-28)26-12-6-10-24(38-26)22-8-2-4-14-36-22/h1-40H;1-32H;1-24H;1-18H
InChIKeyGAXYHLBMRMQOAA-UHFFFAOYSA-N
MW2977.47 g/mol
LogP48.77
Rot. Bonds24

About 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene

6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene (PubChem CID 158201031) has the molecular formula C192H114N26O4S4 and a molecular weight of 2977.47 g/mol. Its IUPAC name is 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene.

Molecular Properties

Compound Name6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene
PubChem CID158201031
Molecular FormulaC192H114N26O4S4
Molecular Weight2977.47 g/mol
Exact Mass2974.84
IUPAC Name6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene
SMILESc1ccc(-c2cc(-c3nc4cc5c(cc4s3)oc3cc4sc(-c6cc(-c7ccccn7)nc(-c7ccccn7)c6)nc4cc35)cc(-c3ccccn3)n2)nc1.c1ccc(-c2cccc(-c3nc4cc5c(cc4n3-c3ccccc3)oc3cc4c(cc35)nc(-c3cccc(-c5ccccc5)c3)n4-c3ccccc3)c2)cc1.c1ccc(-c2cccc(-c3nc4cc5c(cc4s3)oc3cc4sc(-c6cccc(-c7ccccn7)n6)nc4cc35)n2)nc1.c1ccc(-n2c(-c3cccc(-c4nc5cc6c(cc5n4-c4ccccc4)oc4cc5c(cc46)nc(-c4cccc(-c6nc7ccccc7n6-c6ccccc6)c4)n5-c4ccccc4)c3)nc3ccccc32)cc1
InChIInChI=1S/C64H40N8O.C50H32N4O.C44H24N8OS2.C34H18N6OS2/c1-5-23-45(24-6-1)69-55-33-15-13-31-51(55)65-61(69)41-19-17-21-43(35-41)63-67-53-37-49-50-38-54-58(40-60(50)73-59(49)39-57(53)71(63)47-27-9-3-10-28-47)72(48-29-11-4-12-30-48)64(68-54)44-22-18-20-42(36-44)62-66-52-32-14-16-34-56(52)70(62)46-25-7-2-8-26-46;1-5-15-33(16-6-1)35-19-13-21-37(27-35)49-51-43-29-41-42-30-44-46(32-48(42)55-47(41)31-45(43)53(49)39-23-9-3-10-24-39)54(40-25-11-4-12-26-40)50(52-44)38-22-14-20-36(28-38)34-17-7-2-8-18-34;1-5-13-45-29(9-1)33-17-25(18-34(49-33)30-10-2-6-14-46-30)43-51-37-21-27-28-22-38-42(24-40(28)53-39(27)23-41(37)54-43)55-44(52-38)26-19-35(31-11-3-7-15-47-31)50-36(20-26)32-12-4-8-16-48-32;1-3-13-35-21(7-1)23-9-5-11-25(37-23)33-39-27-15-19-20-16-28-32(18-30(20)41-29(19)17-31(27)42-33)43-34(40-28)26-12-6-10-24(38-26)22-8-2-4-14-36-22/h1-40H;1-32H;1-24H;1-18H
InChIKeyGAXYHLBMRMQOAA-UHFFFAOYSA-N
XLogP48.77
TPSA339.94 Ų
H-Bond Donors
H-Bond Acceptors34
Rotatable Bonds24
Heavy Atoms226
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002977.47
LogP ≤ 548.77
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1034

Analyze 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

CID 159617407
CID 159617407
6-Dibenzothiophen-2-yl-3-isocyano-1,9-diphenylcarbazole;3,9-di(dibenzofuran-2-yl)-6-isocyanocarbazole;3-isocyano-6-(1-phenylbenzimidazol-4-yl)-9-[5-[6-(trifluoromethyl)dibenzothiophen-2-yl]-3-pyridinyl]carbazole
CID 160492128
2-[2-[3,6-Bis[3-(1-methyl-5-phenylimidazol-2-yl)phenyl]carbazol-9-yl]-6,8-bis(5-phenyl-1,3-thiazol-2-yl)dibenzofuran-4-yl]-5-phenyl-1,3-thiazole
CID 57958355
18-(3-Imidazo[1,2-a]pyridin-2-ylphenyl)-9-oxa-27-thia-18-azaheptacyclo[18.7.0.02,10.03,8.011,19.012,17.021,26]heptacosa-1(20),2(10),3,5,7,11(19),12,14,16,21,23,25-dodecaene
CID 117726057
2-[2-[3,6-bis[3-(1-methyl-5-phenylimidazol-2-yl)phenyl]carbazol-9-yl]-8-(5-phenyl-1H-imidazol-2-yl)-6-(5-phenyl-1,3-thiazol-2-yl)dibenzofuran-4-yl]-5-phenyl-1,3-thiazole
CID 117983917
2-[2-[3-[3-[1-Methyl-5-(4-methylphenyl)imidazol-2-yl]phenyl]-6-[3-(1-methyl-5-phenylimidazol-2-yl)phenyl]carbazol-9-yl]-6,8-bis(5-phenyl-1,3-thiazol-2-yl)dibenzofuran-4-yl]-5-phenyl-1,3-thiazole
CID 118245953
2-[2-[3,6-bis[3-(1-methyl-5-phenylimidazol-2-yl)phenyl]carbazol-9-yl]-8-(4-phenyl-3H-pyrrol-2-yl)-6-(5-phenyl-1,3-thiazol-2-yl)dibenzofuran-4-yl]-5-phenyl-1,3-thiazole
CID 118446294
2-[2-[3,6-Bis[3-(1-methyl-5-phenylimidazol-2-yl)phenyl]carbazol-9-yl]-8-(5-phenyl-1,3-thiazol-2-yl)-6-(5-phenylthiophen-2-yl)dibenzofuran-4-yl]-5-phenyl-1,3-thiazole
CID 118474430
2-[2-[3,6-bis[3-(1-methyl-5-phenylimidazol-2-yl)phenyl]carbazol-9-yl]-8-(4-phenyl-1H-pyrrol-2-yl)-6-(5-phenyl-1,3-thiazol-2-yl)dibenzofuran-4-yl]-5-phenyl-1,3-thiazole
CID 123589093
5-[4-[3-(1,3-Benzothiazol-2-yl)phenyl]pyrimidin-2-yl]-[1]benzofuro[3,2-c]carbazole
CID 124129779
6-[2-[3-[9-([1]Benzothiolo[3,2-b]pyridin-8-yl)carbazol-3-yl]carbazol-9-yl]imidazo[1,2-a]pyridin-7-yl]-8-[3-(9-imidazo[1,2-a]pyridin-2-ylcarbazol-3-yl)carbazol-9-yl]-[1]benzofuro[3,2-b]pyridine
CID 129253560
7-(9-Pyridin-3-ylcarbazol-3-yl)-6-(28-thia-3-azaheptacyclo[15.11.0.02,10.04,9.011,16.018,27.021,26]octacosa-1(17),2(10),4,6,8,11,13,15,18(27),19,21,23,25-tridecaen-3-yl)-12-oxa-5,8-diazapentacyclo[11.8.0.02,11.04,9.014,19]henicosa-1(13),2,4(9),5,7,10,14,16,18,20-decaene
CID 132081050

Frequently Asked Questions

What is the IUPAC name of 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene?
The IUPAC name of 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene (CID 158201031) is 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene.
What is the SMILES notation for 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene?
The canonical SMILES for 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene is c1ccc(-c2cc(-c3nc4cc5c(cc4s3)oc3cc4sc(-c6cc(-c7ccccn7)nc(-c7ccccn7)c6)nc4cc35)cc(-c3ccccn3)n2)nc1.c1ccc(-c2cccc(-c3nc4cc5c(cc4n3-c3ccccc3)oc3cc4c(cc35)nc(-c3cccc(-c5ccccc5)c3)n4-c3ccccc3)c2)cc1.c1ccc(-c2cccc(-c3nc4cc5c(cc4s3)oc3cc4sc(-c6cccc(-c7ccccn7)n6)nc4cc35)n2)nc1.c1ccc(-n2c(-c3cccc(-c4nc5cc6c(cc5n4-c4ccccc4)oc4cc5c(cc46)nc(-c4cccc(-c6nc7ccccc7n6-c6ccccc6)c4)n5-c4ccccc4)c3)nc3ccccc32)cc1.
What is the InChIKey of 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene?
The InChIKey is GAXYHLBMRMQOAA-UHFFFAOYSA-N. The full InChI is InChI=1S/C64H40N8O.C50H32N4O.C44H24N8OS2.C34H18N6OS2/c1-5-23-45(24-6-1)69-55-33-15-13-31-51(55)65-61(69)41-19-17-21-43(35-41)63-67-53-37-49-50-38-54-58(40-60(50)73-59(49)39-57(53)71(63)47-27-9-3-10-28-47)72(48-29-11-4-12-30-48)64(68-54)44-22-18-20-42(36-44)62-66-52-32-14-16-34-56(52)70(62)46-25-7-2-8-26-46;1-5-15-33(16-6-1)35-19-13-21-37(27-35)49-51-43-29-41-42-30-44-46(32-48(42)55-47(41)31-45(43)53(49)39-23-9-3-10-24-39)54(40-25-11-4-12-26-40)50(52-44)38-22-14-20-36(28-38)34-17-7-2-8-18-34;1-5-13-45-29(9-1)33-17-25(18-34(49-33)30-10-2-6-14-46-30)43-51-37-21-27-28-22-38-42(24-40(28)53-39(27)23-41(37)54-43)55-44(52-38)26-19-35(31-11-3-7-15-47-31)50-36(20-26)32-12-4-8-16-48-32;1-3-13-35-21(7-1)23-9-5-11-25(37-23)33-39-27-15-19-20-16-28-32(18-30(20)41-29(19)17-31(27)42-33)43-34(40-28)26-12-6-10-24(38-26)22-8-2-4-14-36-22/h1-40H;1-32H;1-24H;1-18H.
What are the key properties of 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene?
6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene has a molecular weight of 2977.47 g/mol, XLogP of 48.77, 24 rotatable bonds, 0 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 6,16-bis(2,6-dipyridin-2-yl-4-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;6,16-bis(6-pyridin-2-yl-2-pyridinyl)-11-oxa-7,15-dithia-5,17-diazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis[3-(1-phenylbenzimidazol-2-yl)phenyl]-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene;7,15-diphenyl-6,16-bis(3-phenylphenyl)-11-oxa-5,7,15,17-tetrazapentacyclo[10.7.0.02,10.04,8.014,18]nonadeca-1(19),2,4(8),5,9,12,14(18),16-octaene is sourced from PubChem (CID 158201031), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).